(Q28194354)

1

0 references

X Vidal

2

0 references

L Vendrell

3

0 references

U Moretti

4

0 references

J R Laporte

Alimentary Pharmacology & Therapeutics

5

0 references

language of work or name

English

0 references

publication date

15 January 2006

0 references

published in

0 references

volume

23

0 references

issue

2

0 references

page(s)

235-42

0 references

cites work

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2006.02759.X

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2006.02759.X

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2006.02759.X

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2006.02759.X

Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2006.02759.X

Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

Prophylactic aspirin and risk of peptic ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02759.X